Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/14/18 → 09/14/21 |
Funding
- Amgen Incorporated: $28,166.75
GALACTIC: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Omecamtiv Mecarbil on Mortality and Morbidity in Subjects with Chronic Heart Failure with Reduced Ejection Fraction
- Skopicki, Hal (PI)
- Bloom, Michelle (CoPI)
- Pilato, Lauren (CoPI)
- Tallman, Mark (CoPI)
Project: Research